|
Volumn 62, Issue 12, 2010, Pages 3524-3527
|
Non-overlapping American College of Rheumatology response rates: A better way to report response in rheumatoid arthritis cinical trials
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRHEUMATIC AGENT;
BIOLOGICAL FACTOR;
METHOTREXATE;
CLINICAL TRIAL;
DISEASE CLASSIFICATION;
HEALTH CARE ORGANIZATION;
HUMAN;
NOTE;
RHEUMATOID ARTHRITIS;
RHEUMATOLOGY;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
CHI SQUARE TEST;
CLINICAL ASSESSMENT;
CLINICAL FEATURE;
CONFIDENCE INTERVAL;
MEDICAL SCHOOL;
META ANALYSIS;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
SYSTEMATIC REVIEW;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
CHI-SQUARE DISTRIBUTION;
CLINICAL TRIALS AS TOPIC;
HUMANS;
LINEAR MODELS;
OUTCOME ASSESSMENT (HEALTH CARE);
RHEUMATOLOGY;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
UNITED STATES;
|
EID: 78649890479
PISSN: 21514658
EISSN: 15290131
Source Type: Journal
DOI: 10.1002/art.27711 Document Type: Note |
Times cited : (7)
|
References (6)
|